Rigel Pharmaceuticals
RIGL
#7549
Rank
S$0.31 B
Marketcap
$17.83
Share price
0.44%
Change (1 day)
19.19%
Change (1 year)

Rigel Pharmaceuticals (RIGL) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$0.20 B

According to Rigel Pharmaceuticals's latest financial reports the company's total liabilities are S$0.20 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Rigel Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$0.19 B-2.83%
2022-12-31S$0.19 B7.35%
2021-12-31S$0.18 B82.98%
2020-12-31S$0.10 B-19.93%
2019-12-31S$0.12 B216.59%
2018-12-31S$39.82 M61.24%
2017-12-31S$24.69 M-26.15%
2016-12-31S$33.44 M-41.48%
2015-12-31S$57.14 M67.08%
2014-12-31S$34.2 M51.59%
2013-12-31S$22.56 M-11.97%
2012-12-31S$25.63 M-5.55%
2011-12-31S$27.14 M2.41%
2010-12-31S$26.5 M-38.93%
2009-12-31S$43.39 M-23.98%
2008-12-31S$57.07 M17.46%
2007-12-31S$48.59 M21.83%
2006-12-31S$39.88 M-38.7%
2005-12-31S$65.06 M66.39%
2004-12-31S$39.1 M47.76%
2003-12-31S$26.46 M-19.3%
2002-12-31S$32.79 M1.19%
2001-12-31S$32.4 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$90.29 M-56.21%๐Ÿ‡บ๐Ÿ‡ธ USA
S$84.32 B 40,792.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$110.69 B 53,576.68%๐Ÿ‡บ๐Ÿ‡ธ USA